Drug Safety: Fasinumab Evaluated in Clinical Trials, Plus Celecoxib May Not Pose Increased Heart Attack or Stroke Risk
FDA Staff Raises Safety Concerns Over Arthritis Drug Baricitinib
FDA Update: Possible Heart Risks with Clarithromycin; Apadaz Receives FDA Approval
FDA Receives Reports of Loperamide Abuse
U.S. Life Expectancy Fell in 2016 as Opioid Overdoses Surged—CDC
Limbrel Linked to Possible Fatal Adverse Events
Efficacy Studied Following Accelerated Drug Approvals
Flimsy Evidence Behind Many FDA Approvals
DEA Proposes Cutting Production of Come Opioids
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 17
- Next Page »